Keratinocyte cancer excisions in Australia: who performs them and associated costs
AffiliationDepartment of Population Health, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia
MetadataShow full item record
AbstractBACKGROUND/OBJECTIVE: To describe the clinical settings in which keratinocyte cancers are excised in Queensland and describe the types of practitioners who excise them; to examine costs; and to identify predictors of hospital admission. METHODS: We used linked data for participants from the QSkin study (n = 43 794), including Medicare claims and Queensland hospital admissions relating to treatment episodes for incident keratinocyte cancers from July 2011 to June 2015. We used multinomial logistic regression to measure associations between demographic and clinical characteristics and treatment setting. The median costs of Medicare claims (AU$) were calculated. RESULTS: During 4 years of follow-up, there were 18 479 skin cancer excision episodes among 8613 people. Most excisions took place in private clinical rooms (89.7%), the remainder in hospitals (7.9% private; 2.4% public). Compared with other anatomical sites, skin cancers on the nose, eyelid, ear, lip, finger or genitalia were more likely to be treated in hospitals than in private clinical rooms (public hospital OR 5.7; 95%CI 4.5-7.2; private hospital OR 8.3; 95%CI 7.3-9.4). Primary care practitioners excised 83% of keratinocyte cancers, followed by plastic surgeons (9%) and dermatologists (6%). The median Medicare benefit paid was $253 in private clinical rooms and $334 in private hospitals. Out-of-pocket payments by patients treated in private hospitals were fourfold higher than those in private clinical rooms ($351 vs $80). CONCLUSIONS: Most keratinocyte cancers are excised in primary care, although more than 10% of excisions occur in hospital settings.
CitationThompson BS, Pandeya N, Olsen CM, Dusingize JC, Green AC, Neale RE, et al. Keratinocyte cancer excisions in Australia: who performs them and associated costs. Australas J Dermatol. 2019 Apr 22.
JournalThe Australasian Journal of Dermatology
- The incidence and multiplicity rates of keratinocyte cancers in Australia.
- Authors: Pandeya N, Olsen CM, Whiteman DC
- Issue date: 2017 Oct 16
- Skin cancer excision performance in Scottish primary and secondary care: a retrospective analysis.
- Authors: Haw WY, Rakvit P, Fraser SJ, Affleck AG, Holme SA
- Issue date: 2014 Aug
- A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
- Authors: Rogers HW, Coldiron BM
- Issue date: 2009 Jul
- Factors contributing to incomplete excision of nonmelanoma skin cancer by Australian general practitioners.
- Authors: Hansen C, Wilkinson D, Hansen M, Soyer HP
- Issue date: 2009 Nov
- Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study.
- Authors: Thompson BS, Olsen CM, Subramaniam P, Neale RE, Whiteman DC
- Issue date: 2016 Apr